Prenatal Glucocorticoid Exposure and Autism Spectrum Disorder: Current Evidence, Mechanisms, and Clinical Implications

Saim Mahmood Khan; Jawairya Muhammad Hussain; Yousif Daud Channa; Syed Zawiar Muhammad; Afnan Shaikh; Uzair Virk; Abdullah Aftab Khan; Muhammad Ali Shahzad; Surraiya Riaz Mahmood Khan

doi:10.34763/jmotherandchild.20263001.d-26-00003

.blurhash-client-img { display: none !important; }

Prenatal Glucocorticoid Exposure and Autism Spectrum Disorder: Current Evidence, Mechanisms, and Clinical Implications

Journal of Mother and Child

Volume 30 (2026): Issue 1 (January 2026)

By: Saim Mahmood Khan , Jawairya Muhammad Hussain , Yousif Daud Channa , Syed Zawiar Muhammad , Afnan Shaikh , Uzair Virk , Abdullah Aftab Khan , Muhammad Ali Shahzad and Surraiya Riaz Mahmood Khan

Open Access

|Jul 2026

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed, text rev (DSM-5-TR). Washington, DC: American Psychiatric Association; 2022. doi:10.1176/appi.books.9780890425787
Open DOI Search in Google Scholar Back to article
Zwaigenbaum L, Bauman ML, Stone WL, et al. Early identification of autism spectrum disorder: recommendations for practice and research. Pediatrics. 2015;136 Suppl 1(Suppl 1):S10–S40. doi:10.1542/peds.2014-3667C
Open DOI Search in Google Scholar Back to article
Hyman SL, Levy SE, Myers SM; COUNCIL ON CHILDREN WITH DISABILITIES, SECTION ON DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS. Identification, evaluation, and management of children with autism spectrum disorder. Pediatrics. 2020;145(1):e20193447. doi:10.1542/peds.2019-3447
Open DOI Search in Google Scholar Back to article
Salari N, Rasoulpoor S, Rasoulpoor S, et al. The global prevalence of autism spectrum disorder: a comprehensive systematic review and meta-analysis. Ital. J. Pediatr. 2022;48(1). Doi:10.1186/s13052-022-01310-w
Open DOI Search in Google Scholar Back to article
Maenner MJ, Shaw KA, Baio J, et al. Prevalence of autism spectrum disorder among children aged 8 years — Autism and Developmental Disabilities Monitoring Network, 11 sites, United States, 2016. MMWR Surveillance Summaries. 2020;69(4):1–12. Doi:10.15585/mmwr.ss6904a1
Open DOI Search in Google Scholar Back to article
Talantseva OI, Romanova RS, Shurdova EM, et al. The global prevalence of autism spectrum disorder: A three-level meta-analysis. Front. Psychiatry. 2023;14. Doi:10.3389/fpsyt.2023.1071181
Open DOI Search in Google Scholar Back to article
Masini E, Loi E, Vega-Benedetti AF, et al. An overview of the main genetic, epigenetic and environmental factors involved in autism spectrum disorder focusing on synaptic activity. Int. J. Mol. Sci. 2020;21(21):8290. Doi:10.3390/ijms21218290
Open DOI Search in Google Scholar Back to article
Bandoli G, Palmsten K, Smith CJF, Chambers CD. A review of systemic corticosteroid use in pregnancy and the risk of select pregnancy and birth outcomes. Rheum. Dis. Clin. N. Am. 2017;43(3):489–502. Doi:10.1016/j.rdc.2017.04.013
Open DOI Search in Google Scholar Back to article
Gyamfi-Bannerman C, Thom EA, Blackwell SC, et al. Antenatal betamethasone for women at risk for late preterm delivery. N. Engl. J. Med. 2016;374(14):1311–1320. Doi:10.1056/nejmoa1516783
Open DOI Search in Google Scholar Back to article
Stutchfield P, Whitaker R, Russell I; Antenatal Steroids for Term Elective Caesarean Section (ASTECS) Research Team. Antenatal betamethasone and incidence of neonatal respiratory distress after elective caesarean section: pragmatic randomised trial. BMJ. 2005;331(7518):662. doi:10.1136/bmj.38547.416493.06
Open DOI Search in Google Scholar Back to article
Tao S, Du J, Chi X, et al. Associations between antenatal corticosteroid exposure and neurodevelopment in infants. Am. J. Obstet. Gynecol. 2022;227(5):759.e1–759.e15. doi:10.1016/j.ajog.2022.05.060
Open DOI Search in Google Scholar Back to article
Blencowe H, Cousens S, Chou D, et al. Born Too Soon: The global epidemiology of 15 million preterm births. Reprod. Health. 2013;10(S1). Doi:10.1186/1742-4755-10-s1-s2
Open DOI Search in Google Scholar Back to article
Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972;50(4):515–525. Doi:10.1542/peds.50.4.515
Open DOI Search in Google Scholar Back to article
McGoldrick E, Stewart F, Parker R, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Libr. 2020;2021(2). Doi:10.1002/14651858.cd004454.pub4
Open DOI Search in Google Scholar Back to article
Jobe AH, Goldenberg RL. Antenatal corticosteroids: an assessment of anticipated benefits and potential risks. Am. J. Obstet. Gynecol. 2018;219(1):62–74. Doi:10.1016/j.ajog.2018.04.007
Open DOI Search in Google Scholar Back to article
Guidelines Review Committee. WHO recommendations on interventions to improve preterm birth outcomes. Published November 1, 2015. https://www.who.int/publications/i/item/9789241508988
Search in Google Scholar Back to article
Ballard PL, Ballard RA. Scientific basis and therapeutic regimens for use of antenatal glucocorticoids. Am. J. Obstet. Gynecol. 1995;173(1):254–262. Doi:10.1016/0002-9378(95)90210-4
Open DOI Search in Google Scholar Back to article
Kemp MW, Saito M, Usuda H, et al. Maternofetal pharmacokinetics and fetal lung responses in chronically catheterized sheep receiving constant, low-dose infusions of betamethasone phosphate. Am. J. Obstet. Gynecol. 2016;215(6):775.e1–775.e12. doi:10.1016/j.ajog.2016.08.017
Open DOI Search in Google Scholar Back to article
Bartholomew J, Kovacs L, Papageorgiou A. Review of the antenatal and postnatal use of steroids. Indian J. Pediatr. 2014;81(5):466–472. Doi:10.1007/s12098-014-1376-9
Open DOI Search in Google Scholar Back to article
Haas DM, Lehmann AS, Skaar T, et al. The impact of drug metabolizing enzyme polymorphisms on outcomes after antenatal corticosteroid use. Am. J. Obstet. Gynecol. 2012;206(5):447.e17–447.e24. doi:10.1016/j.ajog.2012.02.016
Open DOI Search in Google Scholar Back to article
Schoenmakers S, Li L, Kluivers ACM, et al. Pharmacokinetics of betamethasone in pre-eclampsia: An in vivo and ex vivo study. Br J Clin Pharmacol. 2025;91(8):2327–2339. doi:10.1002/bcp.70035
Open DOI Search in Google Scholar Back to article
Jobe AH, Milad MA, Peppard T, Jusko WJ. Pharmacokinetics and pharmacodynamics of intramuscular and oral betamethasone and dexamethasone in reproductive age women in India. American Journal of Obstetrics and Gynecology. Clin Transl Sci. 2020;13(2):391–399. doi:10.1111/cts.12724
Open DOI Search in Google Scholar Back to article
Williams MJ, Ramson JA, Brownfoot FC. Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth. Cochrane Libr. 2022;2022(8). Doi:10.1002/14651858.cd006764.pub4
Open DOI Search in Google Scholar Back to article
Ainsworth S. Neonatal Formulary: Drug Use in Pregnancy and the First Year of Life. 7^th ed. Oxford, UK: Oxford University Press; 2020. Doi:10.1093/med/9780198840787.001.0001
Open DOI Search in Google Scholar Back to article
Van Der Merwe JL, Sacco A, Toelen J, Deprest J. Long-term neuropathological and/or neurobehavioral effects of antenatal corticosteroid therapy in animal models: a systematic review. Pediatr. Res. 2019;87(7):1157–1170. Doi:10.1038/s41390-019-0712-1
Open DOI Search in Google Scholar Back to article
Aviram A, Murphy K, McDonald S, et al. Antenatal corticosteroids and neurodevelopmental outcomes in late preterm births. Arch. Dis. Child. Fetal Neonatal Ed. 2021;107(3):250–255. Doi:10.1136/archdischild-2021-322152
Open DOI Search in Google Scholar Back to article
Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and Early-Life conditions on adult health and disease. N. Engl. J. Med. 2008;359(1):61–73. Doi:10.1056/nejmra0708473
Open DOI Search in Google Scholar Back to article
Liauw J, Campbell KSJ, Foggin H, et al. Antenatal corticosteroids and child neurodevelopment. Obstet. Gynecol. Published online June 5, 2025. Doi:10.1097/aog.000000000000595
Open DOI Search in Google Scholar Back to article
Ninan K, Liyanage SK, Murphy KE, Asztalos EV, McDonald SD. Evaluation of long-term outcomes associated with pre-term exposure to antenatal corticosteroids. JAMA Pediatrics. 2022;176(6):e220483. Doi:10.1001/jamapediatrics.2022.0483
Open DOI Search in Google Scholar Back to article
Altman J, A. Bayer S. Atlas of Human Central Nervous System Development. Routledge. https://www.routledge.com/Atlas-of-Human-Central-Nervous-System-Development/book-series/CRCAHCNSD?publishedFilter=alltitles&pd=published,forthcoming&pg=1&pp=12&so=pub&view=list?publishedFilter=alltitles&pd=published,forthcoming&pg=1&pp=12&so=pub&view=list
Search in Google Scholar Back to article
Kwan KY, Lam MMS, Johnson MB, et al. Species-Dependent posttranscriptional regulation of NOS1 by FMRP in the developing cerebral cortex. Cell. 2012;149(4):899–911. Doi:10.1016/j.cell.2012.02.060
Open DOI Search in Google Scholar Back to article
Huttenlocher PR, Dabholkar AS. Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol. 1997;387(2):167–178. Doi:10.1002/(sici)1096-9861(19971020)387:2<;167::aid-cne1>3.0.co;2-z
Open DOI Search in Google Scholar Back to article
Noorlander CW, Tijsseling D, Hessel EVS, et al. Antenatal glucocorticoid treatment affects hippocampal development in mice. PLoS ONE. 2014;9(1):e85671. Doi:10.1371/journal.pone.0085671
Open DOI Search in Google Scholar Back to article
Laugesen K, Skajaa N, Petersen I, et al. Mental disorders among offspring prenatally exposed to systemic glucocorticoids. JAMA Network Open. 2025;8(1):e2453245. Doi:10.1001/jamanetworkopen.2024.53245
Open DOI Search in Google Scholar Back to article
Räikkönen K, Gissler M, Kajantie E. Associations between maternal antenatal corticosteroid treatment and mental and behavioral disorders in children. JAMA. 2020;323(19):1924. Doi:10.1001/jama.2020.3937
Open DOI Search in Google Scholar Back to article
Ram S, Howland MA, Sandman CA, Davis EP, Glynn LM. Prenatal risk for autism spectrum disorder (ASD): Fetal cortisol exposure predicts child ASD symptoms. Clin. Psychol. Sci. 2018;7(2):349–361. Doi:10.1177/2167702618811079
Open DOI Search in Google Scholar Back to article
Wapner RJ, Sorokin Y, Mele L, et al. Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med. 2007;357(12):1190–1198. doi:10.1056/NEJMoa071453
Open DOI Search in Google Scholar Back to article
Dalziel SR, Lim VK, Lambert A, et al. Antenatal exposure to beta-methasone: psychological functioning and health related quality of life 31 years after inclusion in randomised controlled trial. BMJ. 2005;331(7518):665. doi:10.1136/bmj.38576.494363.E0
Open DOI Search in Google Scholar Back to article
Committee Opinion No. 713 Summary: Antenatal corticosteroid therapy for fetal maturation. Obstet. Gynecol. 2017;130(2):493–494. Doi:10.1097/aog.0000000000002231
Open DOI Search in Google Scholar Back to article
Blankenship SA, Brown KE, Simon LE, Stout MJ, Tuuli MG. Antenatal corticosteroids in preterm small-for-gestational age infants: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2020;2(4):100215. Doi:10.1016/j.ajogmf.2020.100215
Open DOI Search in Google Scholar Back to article
Li T, Shen W, Wu F, et al. Antenatal corticosteroids is associated with better postnatal growth outcomes of very preterm infants: A national multicenter cohort study in China. Front Pediatr. 2023;10:1086920. Published 2023 Jan 11. Doi:10.3389/fped.2022.1086920
Open DOI Search in Google Scholar Back to article
Yang X, Ewald ER, Huo Y, et al. Glucocorticoid-induced loss of DNA methylation in non-neuronal cells and potential involvement of DNMT1 in epigenetic regulation of Fkbp5. Biochem Biophys Res Commun. 2012;420(3):570–575. Doi:10.1016/j.bbrc.2012.03.035
Open DOI Search in Google Scholar Back to article
Ito K, Barnes PJ, Adcock IM. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. Mol Cell Biol. 2000;20(18):6891–6903. Doi:10.1128/MCB.20.18.6891-6903.2000
Open DOI Search in Google Scholar Back to article
Bartlett AA, Lapp HE, Hunter RG. Epigenetic mechanisms of the glucocorticoid receptor. Trends Endocrinol Metab. 2019;30(11):807–818. Doi:10.1016/j.tem.2019.07.003
Open DOI Search in Google Scholar Back to article
Paes T, Feelders RA, Hofland LJ. Epigenetic mechanisms modulated by glucocorticoids with a focus on Cushing syndrome. J Clin Endocrinol Metab. 2024;109(6):e1424–e1433. Doi:10.1210/clinem/dgae151
Open DOI Search in Google Scholar Back to article
Rakers F, Schleußner E, Muth I, et al. Association between antenatal glucocorticoid exposure and the activity of the stress system, cognition, and behavior in 8- to 9-year-old children: A prospective observational study. Acta Obstet Gynecol Scand. 2022;101(9):996–1006. Doi:10.1111/aogs.14386
Open DOI Search in Google Scholar Back to article
Ma SL, Chen LH, Lee CC, et al. Genetic overlap between attention deficit/hyperactivity disorder and autism spectrum disorder in SHANK2 gene. Front Neurosci. 2021;15:649588. Published 2021 Apr 27. Doi:10.3389/fnins.2021.649588
Open DOI Search in Google Scholar Back to article
Irwin JL, Meyering AL, Peterson G, et al. Maternal prenatal cortisol programs the infant hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinol. 2021;125:105106. Doi:10.1016/j.psyneuen.2020.105106
Open DOI Search in Google Scholar Back to article
Komoltsev IG, Gulyaeva NV. Brain trauma, glucocorticoids and neuroinflammation: dangerous liaisons for the hippocampus. Biomedicines. 2022;10(5):1139. Published 2022 May 15. Doi:10.3390/biomedicines10051139
Open DOI Search in Google Scholar Back to article
Banker SM, Gu X, Schiller D, Foss-Feig JH. Hippocampal contributions to social and cognitive deficits in autism spectrum disorder. Trends Neurosci. 2021;44(10):793–807. Doi:10.1016/j.tins.2021.08.005
Open DOI Search in Google Scholar Back to article
Knezevic E, Nenic K, Milanovic V, Knezevic NN. The role of cortisol in chronic stress, neurodegenerative diseases, and psychological disorders. Cells. 2023;12(23):2726. Published 2023 Nov 29. Doi:10.3390/cells12232726
Open DOI Search in Google Scholar Back to article
Bilder DA, Worsham W, Sullivan S, et al. Sex-specific and sex-independent steroid-related biomarkers in early second trimester maternal serum associated with autism. Mol Autism. 2023;14(1):30. Published 2023 Aug 12. Doi:10.1186/s13229-023-00562-5
Open DOI Search in Google Scholar Back to article
Kashanian M, Faghankhani M, YousefzadehRoshan M, Ehsani-Pour M, Sheikhansari N. Woman's perceived stress during pregnancy; stressors and pregnancy adverse outcomes. J Matern Fetal Neonatal Med. 2021;34(2):207–215. Doi:10.1080/14767058.2019.1602600
Open DOI Search in Google Scholar Back to article
Alexandraki KI, Kaltsas GA, Chrousos GP. Adrenal Suppression. [Updated 2018 Oct 1]. In: Feingold KR, Ahmed SF, Anawalt B, et al., editors. Endotext [Internet]. South Dartmouth (MA): MD-Text.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279047/
Search in Google Scholar Back to article
Harrewijn A, Vidal-Ribas P, Clore-Gronenborn K, et al. Associations between brain activity and endogenous and exogenous cortisol – A systematic review. Psychoneuroendocrinol. 2020;120:104775. Doi:10.1016/j.psyneuen.2020.104775
Open DOI Search in Google Scholar Back to article
Pofi R, Tomlinson JW. Glucocorticoids in pregnancy. Obstet Med. 2020;13(2):62–69. Doi:10.1177/1753495X19847832
Open DOI Search in Google Scholar Back to article
Ilg L, Klados M, Alexander N, Kirschbaum C, Li SC. Long-term impacts of prenatal synthetic glucocorticoids exposure on functional brain correlates of cognitive monitoring in adolescence. Sci. Rep. 2018 May 16;8(1):7715.
Search in Google Scholar Back to article
Carelli MCB, Peixoto-Filho FM, Velarde LGC, de Sá RAM, Monteiro V, Araujo Júnior E. Effects of antenatal corticosteroids on fetal hemodynamics: a longitudinal study. Radiol Bras. 2024;57:e20230129. Published 2024 May 7. Doi:10.1590/0100-3984.2023.0129
Open DOI Search in Google Scholar Back to article
Mbarek H, et al. Prenatal exposure to topical and systemic corticosteroids and risk of congenital malformations: a cohort study. Eur J Epidemiol. 2022;37(9):951–962.
Search in Google Scholar Back to article
Sigmon ER, Kelleman M, Susi A, Nylund CM, Oster ME. Congenital heart disease and autism: a case-control study. Pediatrics. 2019;144(5):e20184114. Doi:10.1542/peds.2018-4114
Open DOI Search in Google Scholar Back to article
Shimanoe C, Matsumoto A, Hara M, et al. Perceived stress, depressive symptoms, and cortisol-to-cortisone ratio in spot urine in 6878 older adults. Psychoneuroendocrinol. 2021;125:105125. Doi:10.1016/j.psyneuen.2020.105125
Open DOI Search in Google Scholar Back to article
Stalder T, Kirschbaum C. Analysis of cortisol in hair-state of the art and future directions. Brain Behav Immun. 2012;26(7):1019–1029. doi:10.1016/j.bbi.2012.02.002
Open DOI Search in Google Scholar Back to article
Jahnke JR, Terán E, Murgueitio F, Cabrera H, Thompson AL. Maternal stress, placental 11β-hydroxysteroid dehydrogenase type 2, and infant HPA axis development in humans: Psychosocial and physiological pathways. Placenta. 2021;104:179–187. Doi:10.1016/j.placenta.2020.12.008
Open DOI Search in Google Scholar Back to article
Deng J, Chalhoub NE, Sherwin CM, Li C, Brunner HI. Glucocorticoids pharmacology and their application in the treatment of childhood-onset systemic lupus erythematosus. Semin Arthritis Rheum. 2019;49(2):251–259. Doi:10.1016/j.semarthrit.2019.03.010
Open DOI Search in Google Scholar Back to article
Martinez GJ, Appleton M, Kipp ZA, Loria AS, Min B, Hinds TD Jr. Glucocorticoids, their uses, sexual dimorphisms, and diseases: new concepts, mechanisms, and discoveries. Physiol Rev. 2024;104(1):473–532. Doi:10.1152/physrev.00021.2023
Open DOI Search in Google Scholar Back to article
Levitt DG. Pharmacokinetics/pharmacodynamics of glucocorticoids: modeling the glucocorticoid receptor dynamics and dose/response of commonly prescribed glucocorticoids. ADMET DMPK. 2024;12(6):971–989. Published 2024 Oct 19. Doi:10.5599/admet.2414
Open DOI Search in Google Scholar Back to article
He Y, Yi W, Suino-Powell K, et al. Structures and mechanism for the design of highly potent glucocorticoids. Cell Res. 2014;24(6):713–726. Doi:10.1038/cr.2014.52
Open DOI Search in Google Scholar Back to article
Timmermans S, Souffriau J, Libert C. A general introduction to glucocorticoid biology. Front Immunol. 2019;10:1545. Published 2019 Jul 4. Doi:10.3389/fimmu.2019.01545
Open DOI Search in Google Scholar Back to article
Panettieri RA, Schaafsma D, Amrani Y, Koziol-White C, Ostrom R, Tliba O. Non-genomic effects of glucocorticoids: an updated view. Trends Pharmacol Sci. 2019;40(1):38–49. Doi:10.1016/j.tips.2018.11.002
Open DOI Search in Google Scholar Back to article
Nethathe GD, Lipman J, Anderson R, Fuller PJ, Feldman C. Glucocorticoids with or without fludrocortisone in septic shock: a narrative review from a biochemical and molecular perspective. Br J Anaesth. 2024;132(1):53–65. Doi:10.1016/j.bja.2023.10.034
Open DOI Search in Google Scholar Back to article
Yasir M, Goyal A, Sonthalia S. Corticosteroid Adverse Effects. In: StatPearls. Treasure Island (FL): StatPearls Publishing; July 3, 2023.
Search in Google Scholar Back to article
Fowden AL, Vaughan OR, Murray AJ, Forhead AJ. Metabolic consequences of glucocorticoid exposure before birth. Nutrients. 2022;14(11):2304. Published 2022 May 30. Doi:10.3390/nu14112304
Open DOI Search in Google Scholar Back to article
Bontempo AC. Patient attitudes toward clinicians' communication of diagnostic uncertainty and its impact on patient trust. SSM Qual. Res. Health. 2022;3:100214. Doi:10.1016/j.ssmqr.2022.100214
Open DOI Search in Google Scholar Back to article
Vidaeff AC, Belfort MA, Kemp MW, et al. Updating the balance between benefits and harms of antenatal corticosteroids. Am J Obstet Gynecol. 2023;228(2):129–132. Doi:10.1016/j.ajog.2022.10.002
Open DOI Search in Google Scholar Back to article
WHO recommendations on: Antenatal corticosteroids for improving preterm birth outcomes. Geneva: World Health Organization; 2022.
Search in Google Scholar Back to article
Main EK, et al. Reduction of severe maternal morbidity and mortality through a statewide collaborative quality improvement initiative. Am J Obstet Gynecol. 2022;226(2):248.e1–248.e13.
Search in Google Scholar Back to article
De Costa A, Oladapo OT, Gupta S, et al. Antenatal corticosteroids for early preterm birth: implementation strategy lessons from the WHO ACTION-I trial. Health Res Policy Syst. 2022;20(1):141. Published 2022 Dec 28. Doi:10.1186/s12961-022-00941-z
Open DOI Search in Google Scholar Back to article
Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;3(3):CD004454. Published 2017 Mar 21. Doi:10.1002/14651858.CD004454.pub3
Open DOI Search in Google Scholar Back to article
NICE. Overview | Preterm labour and birth | Guidance | NICE. Published November 20, 2015. https://www.nice.org.uk/guidance/ng25
Search in Google Scholar Back to article
Melamed N, Shah J, Soraisham A, et al. Association between antenatal corticosteroid administration-to-birth interval and outcomes of preterm neonates. Obstet Gynecol. 2015;125(6):1377–1384. Doi:10.1097/AOG.0000000000000840
Open DOI Search in Google Scholar Back to article
Norberg H, Kowalski J, Maršál K, Norman M. Timing of antenatal corticosteroid administration and survival in extremely preterm infants: a national population-based cohort study. BJOG. 2017;124(10):1567–1574. Doi:10.1111/1471-0528.14545
Open DOI Search in Google Scholar Back to article
Melamed N, Asztalos E, Murphy K, et al. Neurodevelopmental disorders among term infants exposed to antenatal corticosteroids during pregnancy: a population-based study. BMJ Open. 2019;9(9):e031197. Published 2019 Sep 30. Doi:10.1136/bmjopen-2019-031197
Open DOI Search in Google Scholar Back to article
Crowther CA, Middleton PF, Voysey M, et al. Effects of repeat prenatal corticosteroids given to women at risk of preterm birth: An individual participant data meta-analysis. PLoS Med. 2019;16(4):e1002771. Published 2019 Apr 12. Doi:10.1371/journal.pmed.1002771
Open DOI Search in Google Scholar Back to article
Frändberg J, Sandblom J, Bruschettini M, Maršál K, Kristensen K. Antenatal corticosteroids: a retrospective cohort study on timing, indications and neonatal outcome. Acta Obstet Gynecol Scand. 2018;97(5):591–597. Doi:10.1111/aogs.13301
Open DOI Search in Google Scholar Back to article
Levin HI, Ananth CV, Benjamin-Boamah C, Siddiq Z, Son M, Friedman AM. Clinical indication and timing of antenatal corticosteroid administration at a single centre. BJOG. 2016;123(3):409–414. Doi:10.1111/1471-0528.13730
Open DOI Search in Google Scholar Back to article
Alsayegh E, Barrett J, Melamed N. Optimal timing of antenatal corticosteroids in women with bleeding placenta previa or low-lying placenta. J. Matern. Fetal Neonatal Med. 2018;32(12):1971–1977. Doi:10.1080/14767058.2017.1422713
Open DOI Search in Google Scholar Back to article

Authors

Metrics

Articles in this issue

DOI: https://doi.org/10.34763/jmotherandchild.20263001.d-26-00003 | Journal eISSN: 2719-535X | Journal ISSN: 2719-6488

Journal RSS Feed

Language: English

Page range: 129 - 144

Submitted on: Jan 6, 2026

Accepted on: Apr 2, 2026

Published on: Jul 18, 2026

Published by: Institute of Mother and Child

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

Antenatal corticosteroids,

Autism Spectrum Disorder,

Related subjects:

Pediatrics and juvenile medicine,

Paediatric haematology and oncology,

Public health

© 2026 Saim Mahmood Khan, Jawairya Muhammad Hussain, Yousif Daud Channa, Syed Zawiar Muhammad, Afnan Shaikh, Uzair Virk, Abdullah Aftab Khan, Muhammad Ali Shahzad, Surraiya Riaz Mahmood Khan, published by Institute of Mother and Child
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 30 (2026): Issue 1 (January 2026)